Huron Consulting Group Inc. HURN
We take great care to ensure that the data presented and summarized in this overview for Huron Consulting Group Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HURN
View all-
Vanguard Group Inc Valley Forge, PA1.92MShares$272 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.36MShares$192 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX943KShares$133 Million0.03% of portfolio
-
Boston Partners Boston, MA840KShares$119 Million0.13% of portfolio
-
Morgan Stanley New York, NY636KShares$90 Million0.01% of portfolio
-
Jennison Associates LLC601KShares$85.1 Million0.05% of portfolio
-
Aristotle Capital Boston, LLC Boston, MA584KShares$82.6 Million2.76% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA567KShares$80.2 Million0.17% of portfolio
-
Credit Suisse Ag Zurich, V8515KShares$72.9 Million0.05% of portfolio
-
Sunriver Management LLC Greenwich, CT487KShares$68.9 Million7.33% of portfolio
Latest Institutional Activity in HURN
Top Purchases
Top Sells
About HURN
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, medical groups, and health plans. The Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. The Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.
Insider Transactions at HURN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 09
2025
|
Hope Calder Katz EVP, Gen. Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2
-0.06%
|
$270
$135.54 P/Share
|
|
Apr 02
2025
|
Debra Zumwalt Director |
SELL
Open market or private sale
|
Direct |
223
-0.86%
|
$32,112
$144.33 P/Share
|
|
Apr 02
2025
|
Ekta Singh Bushell Director |
SELL
Open market or private sale
|
Direct |
100
-0.69%
|
$14,400
$144.33 P/Share
|
|
Apr 01
2025
|
John Mccartney Director |
SELL
Open market or private sale
|
Direct |
500
-0.95%
|
$71,000
$142.67 P/Share
|
|
Apr 01
2025
|
H Eugene Lockhart Director |
SELL
Open market or private sale
|
Direct |
1,042
-9.36%
|
$147,964
$142.67 P/Share
|
|
Apr 01
2025
|
Hope Calder Katz EVP, Gen. Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
77
-2.12%
|
$11,011
$143.45 P/Share
|
|
Mar 26
2025
|
James H Roth Director |
SELL
Open market or private sale
|
Direct |
8,641
-3.23%
|
$1,235,663
$143.29 P/Share
|
|
Mar 19
2025
|
James H Roth Director |
SELL
Open market or private sale
|
Direct |
8,642
-4.62%
|
$1,287,658
$149.01 P/Share
|
|
Mar 12
2025
|
James H Roth Director |
SELL
Open market or private sale
|
Direct |
8,642
-3.03%
|
$1,235,806
$143.97 P/Share
|
|
Mar 12
2025
|
John Mccartney Director |
SELL
Open market or private sale
|
Direct |
3,067
-1.86%
|
$441,648
$144.48 P/Share
|
|
Mar 05
2025
|
James H Roth Director |
SELL
Open market or private sale
|
Direct |
8,642
-3.62%
|
$1,270,374
$147.82 P/Share
|
|
Mar 04
2025
|
C. Mark Hussey CEO and President |
SELL
Open market or private sale
|
Direct |
27,672
-5.65%
|
$4,040,112
$146.55 P/Share
|
|
Mar 03
2025
|
John Mccartney Director |
SELL
Open market or private sale
|
Direct |
500
-0.89%
|
$75,500
$151.13 P/Share
|
|
Mar 03
2025
|
H Eugene Lockhart Director |
SELL
Open market or private sale
|
Direct |
1,042
-8.56%
|
$157,342
$151.13 P/Share
|
|
Mar 01
2025
|
Hope Calder Katz EVP, Gen. Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
1,492
+18.89%
|
-
|
|
Mar 01
2025
|
John D. Kelly EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,198
+4.33%
|
-
|
|
Mar 01
2025
|
John D. Kelly EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,459
-16.65%
|
$2,045,768
$152.46 P/Share
|
|
Mar 01
2025
|
Kyle Featherstone Chief Acct Officer, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
366
+17.84%
|
-
|
|
Mar 01
2025
|
Kyle Featherstone Chief Acct Officer, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-11.47%
|
$25,992
$152.46 P/Share
|
|
Mar 01
2025
|
James Ronald Dail Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+4.92%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 175K shares |
|---|
| Payment of exercise price or tax liability | 76.9K shares |
|---|---|
| Open market or private sale | 147K shares |
| Bona fide gift | 2K shares |